Trodelvy deal by Gilead wasn’t a bidding war. In
Post# of 148162
They had 3 interested parties and the CEO took over the company in 2018 with a campaign against the current management. Sounds familiar? Maybe what the inept 13d group was trying to do? These two links are Gileads web site release and an independent article from FiercePharma which is unlike Fiercebiotech and is not a short driven internet publication.
https://www.fiercepharma.com/pharma/immunomed...idding-war
https://www.gilead.com/news-and-press/press-r...medics-inc